For the year ending 2025-12-31, LMAT made $249,602K in revenue. $57,734K in net income. Net profit margin of 23.13%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Net sales | 249,602 | 219,863 | ||
| Cost of sales | 71,063 | 68,962 | ||
| Gross profit | 178,539 | 150,901 | ||
| Sales and marketing | 54,464 | 46,737 | ||
| General and administrative | 42,024 | 36,258 | ||
| Research and development | 14,139 | 15,650 | ||
| Restructuring | 0 | - | ||
| Total operating expenses | 110,627 | 98,645 | ||
| Income from operations | 67,912 | 52,256 | ||
| Investment income | 13,094 | 4,949 | ||
| Interest expense | 5,184 | 205 | ||
| Other income (loss), net | -638 | -125 | ||
| Income before income taxes | 75,184 | 56,875 | ||
| Provision for income taxes | 17,450 | 12,837 | ||
| Net income | 57,734 | 44,038 | ||
| Basic EPS | 2.55 | 1.96 | ||
| Diluted EPS | 2.52 | 1.93 | ||
| Basic Average Shares | 22,638,000 | 22,452,000 | ||
| Diluted Average Shares | 22,929,000 | 22,779,000 | ||
LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT)